Voglibose Market Key Drivers and Forecast 2025-2032
Voglibose Market Trends And Drivers The Voglibose market was valued at approximately USD 2.1 Billion in 2022 and is projected to reach USD 4.1 Billion by 2030, growing at a Compound Annual Growth Rate (CAGR) of 8.6% from 2024 to 2030. Voglibose, an oral α-glucosidase inhibitor primarily used to manage type 2 diabetes, has seen […]
Continue Reading